Chapter 050

Oral Complications of Cancer Therapy

Rajesh V. Lalla, Michael T. Brennan, and Mark M. Schubert

CITED REFERENCES

  1. Aapro MS: How do we manage patients with refractory or breakthrough emesis? Support Care Cancer 10:106-109, 2002. PUBMED Abstract
  2. Bamias A, Kastritis E, Bamia C, et al: Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 23:8580-8587, 2005. PUBMED Abstract
  3. Barasch A, Elad S, Altman A, et al: Antimicrobials, mucosal coating agents, anesthetics, analgesics, and nutritional supplements for alimentary tract mucositis. Support Care Cancer 14:528-532, 2006. PUBMED Abstract
  4. Bellm LA, Epstein JB, Rose-Ped A, et al: Patient reports of complications of bone marrow transplantation. Support Care Cancer 8:33-39, 2000. PUBMED Abstract
  5. Bensadoun RJ, Franquin JC, Ciais G, et al: Low-energy He/Ne laser in the prevention of radiation-induced mucositis: a multicenter phase III randomized study in patients with head and neck cancer. Support Care Cancer 7:244-252, 1999. PUBMED Abstract
  6. Bensadoun RJ, Schubert MM, Lalla RV, et al: Amifostine in the management of radiation-induced and chemo-induced mucositis. Support Care Cancer 14:566-572, 2006. PUBMED Abstract
  7. Birek C, Patterson B, Maximiw WC, et al: EBV and HSV infections in a patient who had undergone bone marrow transplantation: oral manifestations and diagnosis by in situ nucleic acid hybridization. Oral Surg Oral Med Oral Pathol 68:612-617, 1989. PUBMED Abstract
  8. Borowski B, Benhamou E, Pico JL, et al: Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomised controlled trial comparing two protocols of dental care. Eur J Cancer B Oral Oncol 30B:93-97, 1994. PUBMED Abstract
  9. Brizel DM, Wasserman TH, Henke M, et al: Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 18:3339-3345, 2000. PUBMED Abstract
  10. Cheng KK, Molassiotis A, Chang AM, et al: Evaluation of an oral care protocol intervention in the prevention of chemotherapy-induced oral mucositis in paediatric cancer patients. Eur J Cancer 37:2056-2063, 2001. PUBMED Abstract
  11. Clarkson JE, Worthington HV, Eden OB: Interventions for preventing oral candidiasis for patients with cancer receiving treatment. Cochrane Database Syst Rev (1):CD003807, 2007. PUBMED Abstract
  12. Comeau TB, Epstein JB, Migas C: Taste and smell dysfunction in patients receiving chemotherapy: a review of current knowledge. Support Care Cancer 9:575-580, 2001. PUBMED Abstract
  13. Conger AD: Loss and recovery of taste acuity in patients irradiated to the oral cavity. Radiat Res 53:338-347, 1973. PUBMED Abstract
  14. Cullen M, Steven N, Billingham L, et al: Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. N Engl J Med 353:988-998, 2005. PUBMED Abstract
  15. Dahllof G, Barr M, Bolme P, et al: Disturbances in dental development after total body irradiation in bone marrow transplant recipients. Oral Surg Oral Med Oral Pathol 65:41-44, 1988. PUBMED Abstract
  16. Duncan GG, Epstein JB, Tu D, et al: Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis. Head Neck 27:421-428, 2005. PUBMED Abstract
  17. Elting LS, Cooksley C, Chambers M, et al: The burdens of cancer therapy: clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 98:1531-1539, 2003. PUBMED Abstract
  18. Elting LS, Cooksley CD, Chambers MS, et al: Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys 68(4):1110-1120, 2007. PUBMED Abstract
  19. Epstein JB, Burchell JL, Emerton S, et al: A clinical trial of bethanechol in patients with xerostomia after radiation therapy: a pilot study. Oral Surg Oral Med Oral Pathol 77:610-614, 1994. PUBMED Abstract
  20. Epstein JB, Emerton S, Le ND, et al: A double-blind crossover trial of Oral Balance gel and Biotene toothpaste versus placebo in patients with xerostomia following radiation therapy. Oral Oncol 35:132-137, 1999. PUBMED Abstract
  21. Epstein JB, Loh R, Stevenson-Moore P, et al: Chlorhexidine rinse in prevention of dental caries in patients following radiation therapy. Oral Surg Oral Med Oral Pathol 68:401-405, 1989. PUBMED Abstract
  22. Epstein JB, Phillips N, Parry J, et al: Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 30:785-792, 2002. PUBMED Abstract
  23. Epstein JB, Rea G, Wong FL, et al: Osteonecrosis: study of the relationship of dental extractions in patients receiving radiotherapy. Head Neck Surg 10:48-54, 1987. PUBMED Abstract
  24. Epstein JB, Silverman S Jr, Paggiarino DA, et al: Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial. Cancer 92:875-885, 2001. PUBMED Abstract
  25. Epstein JB, Stevenson-Moore P: A clinical comparative trial of saliva substitutes in radiation-induced salivary gland hypofunction. Spec Care Dentist 12:21-23, 1992. PUBMED Abstract
  26. Epstein JB, van der Meij EH, Lunn R, et al: Effects of compliance with fluoride gel application on caries and caries risk in patients after radiation therapy for head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 82:268-275, 1996. PUBMED Abstract
  27. Garcia-Hermoso D, Dromer F, Improvisi L, et al: Fluconazole concentrations in saliva from AIDS patients with oropharyngeal candidiasis refractory to treatment with fluconazole. Antimicrob Agents Chemother 39:656-660, 1995. PUBMED Abstract
  28. Gluckman E, Lotsberg J, Devergie A, et al: Oral acyclovir prophylactic treatment of herpes simplex infection after bone marrow transplantation. J Antimicrob Chemother 12(Suppl B):161-167, 1983. PUBMED Abstract
  29. Greenberg MS, Cohen SG, McKitrick JC, et al: The oral flora as a source of septicemia in patients with acute leukemia. Oral Surg Oral Med Oral Pathol 53:32-36, 1982. PUBMED Abstract
  30. Halyard MY, Jatoi A, Sloan JA, et al: Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4). Int J Radiat Oncol Biol Phys 67:1318-1322, 2007. PUBMED Abstract
  31. Hayes C: The effect of non-cariogenic sweeteners on the prevention of dental caries: a review of the evidence. J Dent Educ 65:1106-1109, 2001. PUBMED Abstract
  32. Huang WT, Chang LY, Hsueh PR, et al: Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients. J Microbiol Immunol Infect 40:349-354, 2007. PUBMED Abstract
  33. Jaffe N, Toth BB, Hoar RE, et al: Dental and maxillofacial abnormalities in long-term survivors of childhood cancer: effects of treatment with chemotherapy and radiation to the head and neck. Pediatrics 73:816-823, 1984. PUBMED Abstract
  34. Jankovic L, Jelic S, Filipovic-Ljeskovic I, et al: Salivary immunoglobulins in cancer patients with chemotherapy-related oral mucosa damage. Eur J Cancer B Oral Oncol 31B:160-165, 1995. PUBMED Abstract
  35. Jham BC, Teixeira IV, Aboud CG, et al: A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer. Oral Oncol 43:137-142, 2007. PUBMED Abstract
  36. Jordan K, Sippel C, Schmoll HJ: Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations. Oncologist 12:1143-1150, 2007. PUBMED Abstract
  37. Keefe DM, Schubert MM, Elting LS, et al: Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109:820-831, 2007. PUBMED Abstract
  38. Koks CH, Crommentuyn KM, Hoetelmans RM, et al: Can fluconazole concentrations in saliva be used for therapeutic drug monitoring? Ther Drug Monit 23:449-453, 2001. PUBMED Abstract
  39. Kunz M, Wilhelm S, Freund M, et al: Treatment of severe erythrodermic acute graft-versus-host disease with photochemotherapy. Br J Dermatol 144:901-902, 2001. PUBMED Abstract
  40. Laine PO, Lindqvist JC, Pyrhonen SO, et al: Oral infection as a reason for febrile episodes in lymphoma patients receiving cytostatic drugs. Eur J Cancer B Oral Oncol 28B:103-107, 1992. PUBMED Abstract
  41. Laine P, Meurman JH, Tenovuo J, et al: Salivary flow and composition in lymphoma patients before, during and after treatment with cytostatic drugs. Eur J Cancer B Oral Oncol 28B:125-128, 1992. PUBMED Abstract
  42. Lalla RV, Peterson DE: Oral mucositis. Dent Clin North Am 49:167-184, 2005. PUBMED Abstract
  43. Lalla RV, Peterson DE: Treatment of mucositis, including new medications. Cancer J 12:348-354, 2006. PUBMED Abstract
  44. Lalla RV, Schubert MM, Bensadoun RJ, et al: Anti-inflammatory agents in the management of alimentary mucositis. Support Care Cancer 14:558-565, 2006. PUBMED Abstract
  45. Lalla RV: Velafermin (CuraGen). Curr Opin Investig Drugs 6:1179-1185, 2005. PUBMED Abstract
  46. LeVeque FG, Montgomery M, Potter D, et al: A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. J Clin Oncol 11:1124-1131, 1993. PUBMED Abstract
  47. Levy-Polack MP, Sebelli P, Polack NL: Incidence of oral complications and application of a preventive protocol in children with acute leukemia. Spec Care Dentist 18:189-193, 1998. PUBMED Abstract
  48. Lloid ME, Schubert MM, Myerson D, et al: Cytomegalovirus infection of the tongue following marrow transplantation. Bone Marrow Transplant 14:99-104, 1994. PUBMED Abstract
  49. Lockhart PB, Sonis ST: Alterations in the oral mucosa caused by chemotherapeutic agents: a histologic study. J Dermatol Surg Oncol 7:1019-1025, 1981. PUBMED Abstract
  50. Maguire A, Welbury RR: Long-term effects of antineoplastic chemotherapy and radiotherapy on dental development. Dent Update 23:188-194, 1996. PUBMED Abstract
  51. Mavrokokki T, Cheng A, Stein B, et al: Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 65:415-423, 2007. PUBMED Abstract
  52. McCarthy GM, Skillings JR: A prospective cohort study of the orofacial effects of vincristine neurotoxicity. J Oral Pathol Med 20:345-349, 1991. PUBMED Abstract
  53. McGuire DB, Correa ME, Johnson J, et al: The role of basic oral care and good clinical practice principles in the management of oral mucositis. Support Care Cancer 14:541-547, 2006. PUBMED Abstract
  54. Migliorati CA, Casiglia J, Epstein J, et al: Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper. J Am Dent Assoc 136:1658-1668, 2005. PUBMED Abstract
  55. Migliorati CA, Oberle-Edwards L, Schubert M: The role of alternative and natural agents, cryotherapy, and/or laser for management of alimentary mucositis. Support Care Cancer 14:533-540, 2006. PUBMED Abstract
  56. Migliorati CA, Siegel MA, Elting LS: Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment. Lancet Oncol 7:508-514, 2006. PUBMED Abstract
  57. Myers RA, Marx RE: Use of hyperbaric oxygen in postradiation head and neck surgery. NCI Monogr 9:151-157, 1990. PUBMED Abstract
  58. Nagler RM, Nagler A: Major salivary gland involvement in graft-versus-host disease: considerations related to pathogenesis, the role of cytokines and therapy. Cytokines Cell Mol Ther 5:227-232, 1998. PUBMED Abstract
  59. Nagy K, Urban E, Fazekas O, et al: Controlled study of lactoperoxidase gel on oral flora and saliva in irradiated patients with oral cancer. J Craniofac Surg 18:1157-1164, 2007. PUBMED Abstract
  60. Oneschuk D, Hanson J, Bruera E: A survey of mouth pain and dryness in patients with advanced cancer. Support Care Cancer 8:372-376, 2000. PUBMED Abstract
  61. Osoba D, Zee B, Warr D, et al: Effect of postchemotherapy nausea and vomiting on health-related quality of life. The Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group. Support Care Cancer 5:307-313, 1997. PUBMED Abstract
  62. Peterson DE: Pretreatment strategies for infection prevention in chemotherapy patients. NCI Monogr 9:61-71, 1990. PUBMED Abstract
  63. Peterson DE, Jones JB, Petit RG 2nd: Randomized, placebo-controlled trial of Saforis for prevention and treatment of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy. Cancer 109:322-331, 2007. PUBMED Abstract
  64. Peterson DE, Keefe DM, Hutchins RD, et al: Alimentary tract mucositis in cancer patients: impact of terminology and assessment on research and clinical practice. Support Care Cancer 14:499-504, 2006. PUBMED Abstract
  65. Pizzo PA, Ladisch S, Witebsky FG: Alpha-hemolytic streptococci: clinical significance in the cancer patient. Med Pediatr Oncol 4:367-370, 1978. PUBMED Abstract
  66. Redding SW, Callander NS, Haveman CW, et al: Treatment of oral chronic graft-versus-host disease with PUVA therapy: case report and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 86:183-187, 1998. PUBMED Abstract
  67. Rosenberg SW, Kolodney H, Wong GY, et al: Altered dental root development in long-term survivors of pediatric acute lymphoblastic leukemia: a review of 17 cases. Cancer 59:1640-1648, 1987. PUBMED Abstract
  68. RxKinetix completes its end of phase 2 meeting with the FDA for RK-0202 in oral mucositis and is now moving into phase 3 (press release), Boulder, CO, 2006, RxKinetix, Inc.
  69. Sandow PL, Hejrat-Yazdi M, Heft MW: Taste loss and recovery following radiation therapy. J Dent Res 85:608-611, 2006. PUBMED Abstract
  70. Schubert MM: Oral manifestations of viral infections in immunocompromised patients. Curr Opin Dent 1:384-397, 1991. PUBMED Abstract
  71. Schubert MM, Eduardo FP, Guthrie KA, et al: A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation. Support Care Cancer 15(10):1145-1154, 2007. PUBMED Abstract
  72. Schubert MM, Epstein JB, Lloid ME, et al: Oral infections due to cytomegalovirus in immunocompromised patients. J Oral Pathol Med 1993;22:268-273. PUBMED Abstract
  73. Schubert MM, Peterson DE, Flournoy N, et al: Oral and pharyngeal herpes simplex virus infection after allogeneic bone marrow transplantation: analysis of factors associated with infection. Oral Surg Oral Med Oral Pathol 70:286-293, 1990. PUBMED Abstract
  74. Schubert MM, Sullivan KM, Morton TH, et al: Oral manifestations of chronic graft-v-host disease. Arch Intern Med 144:1591-1595, 1984. PUBMED Abstract
  75. Shafran SD, Tyring SK, Ashton R, et al: Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial. J Clin Virol 29:248-253, 2004. PUBMED Abstract
  76. Silverman S Jr: Oral cancer: complications of therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88:122-126, 1999. PUBMED Abstract
  77. Sonis ST, Elting LS, Keefe D, et al: Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100(9 Suppl):1995-2025, 2004. PUBMED Abstract
  78. Sonis ST, Oster G, Fuchs H, et al: Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 19:2201-2205, 2001. PUBMED Abstract
  79. Spielberger R, Stiff P, Bensinger W, et al: Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 351:2590-2598, 2004. PUBMED Abstract
  80. Stiff P: Mucositis associated with stem cell transplantation: current status and innovative approaches to management. Bone Marrow Transplant 27(Suppl 2):S3-S11, 2001. PUBMED Abstract
  81. Trotti A, Bellm LA, Epstein JB, et al: Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 66:253-262, 2003. PUBMED Abstract
  82. Vera-Llonch M, Oster G, Ford CM, et al: Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies. Support Care Cancer 15:491-496, 2007. PUBMED Abstract
  83. Vera-Llonch M, Oster G, Hagiwara M, et al: Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer 106:329-336, 2006. PUBMED Abstract
  84. Vigouroux S, Morin O, Moreau P, et al: Candidemia in patients with hematologic malignancies: analysis of 7 years’ experience in a single center. Haematologica 91:717-718, 2006. PUBMED Abstract
  85. von Bultzingslowen I, Brennan MT, Spijkervet FK, et al: Growth factors and cytokines in the prevention and treatment of oral and gastrointestinal mucositis. Support Care Cancer 14:519-527, 2006. PUBMED Abstract
  86. Wang R, Boyle A: A convenient method for guarding against localized mucositis during radiation therapy. J Prosthodont 3:198-201, 1994. PUBMED Abstract
  87. Worthington HV, Clarkson JE, Eden OB: Interventions for treating oral candidiasis for patients with cancer receiving treatment. Cochrane Database Syst Rev (2):CD001972, 2007. PUBMED Abstract

GENERAL REFERENCES

  1. Lalla RV, Peterson DE, Brennan MT, et al: Oral toxicity. In Perry MC, editor: The chemotherapy sourcebook, ed 4, Lippincott, 2008, Williams & Wilkins.
  2. National Cancer Institute: Oral complications of chemotherapy and head/neck radiation. Available at: http://www.cancer.gov/cancertopics/pdq/supportivecare/oralcomplications/healthprofessional. Accessed January 23, 2010.
  3. Schubert MM, Peterson DE: Oral complications. In Thomas ED, Blume KG, Forman SJ, editors: Hematopoietic cell transplantation, ed 3, Oxford, 2008, Blackwell Science.